Müller, Michael
Pavlovic, Ana
Niermann, Theresa
Pavlovic, Ivana
Priglinger, Siegfried
Kohnen, Thomas http://orcid.org/0000-0002-6933-9585
Shajari, Mehdi
Mackert, Marc
Funding for this research was provided by:
Johann Wolfgang Goethe-Universität, Frankfurt am Main
Article History
Received: 31 May 2021
Accepted: 9 July 2023
First Online: 2 September 2023
Declarations
:
: M. Müller: <i>Consultant</i> for Théa, Alcon, Novartis, Allergan. A. Pavlovic: No financial interests to declare. T. Niermann: No financial interests to declare. I. Pavlovic: No financial interests to declare. M. Mackert: No financial interests to declare. S. Priglinger: <i>Consultant</i> for Oertli and Novartis; <i>Grants</i> from Alcon, Bayer, Novartis, and Zeiss. M. Shajari: <i>Consultant</i> for Alcon, Zeiss, Staar, and Oculus. T. Kohnen: <i>Consultant and Research</i> for Abbott/J&J, Alcon/Novartis, Avedro, Oculentis, Oculus, Presbia, Schwind, Zeiss. <i>Consultant</i> for Allergan, Bausch & Lomb, Dompé, Geuder, Med Update, Merck, Rayner, Santen, Staar, Tear Lab, Théa, Thieme, Ziemer. <i>Research</i> for Hoya.
: The study protocol of this retrospective study was approved by the ethics committee of the Goethe University, Frankfurt am Main, Germany.
: Written informed consent was not required, because data were analysed in a pseudonymic way.